
August 10, 2020
How to Participate in a COVID-19 Vaccine Clinical Trial
A phase III clinical trial for the vaccine produced by Moderna is seeking 30,000 participants across the country.
August 10, 2020
A phase III clinical trial for the vaccine produced by Moderna is seeking 30,000 participants across the country.
July 8, 2020
With facemask donations pouring in and a proliferation of instructional videos for fabricating masks at home, UNC and EPA researchers are collaborating with infection prevention experts to test the performance of masks on campus, with the goal of providing UNC Health workers with the safest available masks at all times. The research collaboration is led by Emily Sickbert-Bennett, PhD, and Phillip Clapp, PhD.
May 26, 2020
The UNC School of Medicine lab of Stanley M. Lemon, MD, and colleagues used CRISPR-Cas9 gene editing to pinpoint a sugar-fatty acid molecule that acts like a gatekeeper to hepatitis A virus infection of human cells.
July 10, 2019
Scott Commins, MD, PhD, continues to research “alpha-gal” meat allergy and create awareness for the tick-borne illness as a new CDC research study begins. Recognized as a leading national expert, Commins will now guide a US DHHS Tick-Borne Working Group Subcommittee.
June 12, 2019
Emily Ciccone, MD, MHS, will use the $25,000 award to differentiate viral and bacterial respiratory infections among malaria-negative children. The overall goal is to reduce unnecessary antibiotic use without compromising safety in an area where access to care is a real issue.
October 4, 2018
Discovery by Ross Boyce, MD, MSc, clinical instructor in the Division of Infectious Diseases, shows need for statewide educational efforts.
June 13, 2012
"Life is like riding a bicycle. To keep your balance you must keep moving." - Albert Einstein. Infectious Diseases doctors van der Horst and Wohl discuss life balance while riding early one morning near Hillsborough, N.C.
March 30, 2011
Clinical staff will begin to see a new isolation sign on the patient care units. The new sign is Enteric Contact Precautions and is being used for patients who have active infection with C. difficile, rotavirus, or norovirus.